Michael Aronstein serves as Executive at AngioGenex, Inc., where they oversee executive responsibilities. Since joining the company, Michael Aronstein has executed 9 insider transactions totaling $200.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 31, 2021 involved receiving (via award) 750,000 shares valued at $0.
Michael Aronstein currently holds 7,507,827 shares of AngioGenex, Inc. (AGGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael Aronstein has been a net buyer of AGGX stock. They have purchased $200.0K and sold $0 worth of shares.
Michael Aronstein's most recent insider trade was on Aug 31, 2021, when they sold 750,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $25000.00 |
| Discretionary |
| Mar 2, 2021 | AGGX | $0 | Award | 400,000 | $N/A | Discretionary |
| Oct 8, 2020 | AGGX | $555.5M | Award | 55,555 | $10000.00 | Discretionary |
| Aug 5, 2020 | AGGX | $500.0M | Award | 50,000 | $10000.00 | Discretionary |
| Mar 3, 2020 | AGGX | $125.0M | Award | 25,000 | $5000.00 | Discretionary |
| Dec 30, 2019 | AGGX | $0 | Award | 250,000 | $25000.00 | Discretionary |
| Oct 23, 2019 | AGGX | $0 | Award | 250,000 | $25000.00 | Discretionary |
| Jan 15, 2019 | AGGX | $200.0K | Purchase | 1,000,000 | $0.20 | Discretionary |